KLHL24 associated cardiomyopathy: Gene function to clinical management

Area of Science:

• Genetics and Molecular Biology
• Cardiology
• Dermatology

Background:

• Kelch-like protein 24 (KLHL24) is integral to the ubiquitin-proteasome system, regulating protein degradation.
• Germline KLHL24 mutations previously linked to Epidermolysis Bullosa Simplex now also implicated in cardiomyopathy.
• KLHL24 dysfunction impacts cardiac protein stability, leading to structural and functional cardiac abnormalities.

Purpose of the Study:

• To review and synthesize research on KLHL24 gene mutations and their association with various cardiomyopathies.
• To explore the molecular mechanisms and pathophysiologies underlying KLHL24-associated diseases.
• To highlight the clinical significance of KLHL24 mutations in cardiomyopathy for improved patient outcomes.

Main Methods:

• Comprehensive literature review of studies on KLHL24 gene mutations from 2016 to 2024.
• Keywords used: KLHL24 gene, hypertrophic cardiomyopathy, dilated cardiomyopathy, epidermolysis bullosa simplex.
• Analysis of proposed molecular mechanisms, pathophysiologies, clinical presentations, and current treatment strategies.

Main Results:

• KLHL24 mutations are associated with both hypertrophic and dilated cardiomyopathies.
• Clinical manifestations include skin fragility, cardiac symptoms, skeletal muscle weakness, and neurological issues.
• Current treatments are symptomatic; no specific clinical trials for KLHL24-mutation-related therapies are underway.

Conclusions:

• KLHL24 mutations represent a significant, newly recognized cause of cardiomyopathy.
• Further understanding of KLHL24's role is vital for developing targeted diagnostic and therapeutic strategies.
• This research emphasizes the need for improved clinical diagnosis and targeted therapies for better patient outcomes.